Gold nanoparticles effectively deliver CRISPR to mouse models of DMD | Fierce Biotech

Gold nanoparticles effectively deliver CRISPR to mouse models of DMD | Fierce Biotech
Article by
Article Date
August 9, 2023
Category
Portfolio

Related posts

Browse all articles
Portfolio
August 6, 2023

Sarepta rushes for GenEdit's polymer nanoparticles in $57M gene editing delivery partnership | Fierce Biotech

Sarepta Therapeutics will pay GenEdit up to $57 million in the near-term for access to the

Portfolio
August 6, 2023

Making Lemonade Out of Lemons: Climate and Clean Air Action During a Pandemic

Can the pandemic teach us about reducing emissions? Find out in our latest blog post.